28. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
11.11. - 12.11.2021, digital
Abstracts
Meeting Abstract
(21gaa01)
[Volltext]
Reduction of medicines by GPs in frail elderly patients using a standardised deprescribing manual during family conferences – the COFRAIL study
Bencheva V, Gogolin M, Mann NK, Schmiedl S, Abraham J, Drewelow E, Ritzke M, Icks A, Mortsiefer A, Wiese B, Wilm S, Thürmann PA[Volltext]
Meeting Abstract
(21gaa02)
[Volltext]
Prioritisation of adverse drug events leading to hospital admission and occurring during hospitalisation: A RAND survey
Böhmer A, Härdtlein A, Rottenkolber M, Pudritz YM, Dreischulte T, Jaehde U[Volltext]
Meeting Abstract
(21gaa03)
[Volltext]
A prospective study on the tolerability of vaccines against SARS-CoV-2 in hospital staff
Dedroogh S, Graf K, Schmiedl S, Thürmann PA, Koß R, Theis C, Tebbenjohanns J, Thal S, Dedroogh M[Volltext]
Meeting Abstract
(21gaa04)
[Volltext]
Guidelines for drug therapy after osteoporosis-associated bone fractures: to what extent are they followed in everyday practice?
Eichler U, Langner I, Schüssel K, Selke GW[Volltext]
Meeting Abstract
(21gaa05)
[Volltext]
Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave
Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M[Volltext]
Meeting Abstract
(21gaa06)
[Volltext]
Cannabis-Report 2020 – An analysis of prescriptions of cannabinoid-based medicinal products based on data of the Mobil health insurance from 2017 until October 2019
Glaeske G, Muth L[Volltext]
Meeting Abstract
(21gaa07)
[Volltext]
Prescription of potentially teratogenic drugs in women of childbearing age and during first trimester of pregnancy in a large cohort of statutory health insured women
Lappe V, Schubert I, Grandt D[Volltext]
Meeting Abstract
(21gaa08)
[Volltext]
Updating and expanding the PRISCUS list – Results from the Delphi survey
Mann NK, Mathes T, Sönnichsen A, Pieper D, Moussa M, Thürmann PA[Volltext]
Meeting Abstract
(21gaa09)
[Volltext]
Differential effects of beta-blocker exposures in predicting specific readmissions for heart failure and myocardial infarction
Meid A, Wirbka L, Ruff C, Haefeli W[Volltext]
Meeting Abstract
(21gaa10)
[Volltext]
Bewertungskriterien für Gesundheitsapps zur Unterstützung der Medikamenteneinnahme in frühen Entwicklungsphasen der Technologie – ein Scoping Review
Niemann A, Hüer T, Neumann A, Wasem J, Neusser S[Volltext]
Meeting Abstract
(21gaa11)
[Volltext]
Risk of fall injuries while taking hypnotics, antidepressants, and analgesics
Oehler P, Rottenkolber M, Drey M, Gensichen J, Dreischulte T[Volltext]
Meeting Abstract
(21gaa12)
[Volltext]
From vaccine approval to reimbursement: an analysis of discrepancies between label according to marketing authorization and indication for reimbursement listed in the Vaccination Policy (SI-RL) in Germany
Prünte L, Barth M, Urban J[Volltext]
Meeting Abstract
(21gaa13)
[Volltext]
Melanoma reported as an adverse drug reaction
Sachs B, Dubrall D, Kraywinkel K, Schulz M, Schmid M, Bäte J, Fischer-Barth W[Volltext]
Meeting Abstract
(21gaa14)
[Volltext]
Changes in drug prescriptions during the SARS-CoV-2 pandemic
Schüssel K, Selke GW[Volltext]
Meeting Abstract
(21gaa15)
[Volltext]
Corona pandemic-related differences in drug prescriptions within the outpatient treatment of the Statutory Health Insurance in Schleswig-Holstein from 2019 until 2020
Schuster R, Emcke T[Volltext]
Meeting Abstract
(21gaa16)
[Volltext]
Serious Adverse Drug Reactions of Fluoroquinolones: a Pharmacoepidemiological Real World Data Analysis – Study Protocol
Wicherski J, Heß S, Röthlein C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern W, Weltermann B, Haenisch B[Volltext]
Meeting Abstract
(21gaa17)
[Volltext]
The Role of adherence to multiple guideline medications in predicting specific readmissions for heart failure and myocardial infarction
Wirbka L, Ruff C, Haefeli W, Meid A[Volltext]
